Thus, manipulation of the lysosome dynamics and activity may represent a possible therapeutic strategy for delaying disease progression in ALS cases associated with FUS mutations (Marrone et al., 2019) and related neurodegenerative diseases where proteins able to phase separate could form aberrant insoluble aggregates (Wallings et al., 2019). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.